Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
260K
-
Shares change
-
+148K
-
Total reported value, excl. options
-
$8.9M
-
Value change
-
+$5.03M
-
Number of buys
-
13
-
Number of sells
-
-6
-
Price
-
$34.09
Significant Holders of Greenwich LifeSciences, Inc. - COM (GLSI) as of Q1 2021
22 filings reported holding GLSI - Greenwich LifeSciences, Inc. - COM as of Q1 2021.
Greenwich LifeSciences, Inc. - COM (GLSI) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 260K shares
.
Largest 10 shareholders include VANGUARD GROUP INC (106K shares), BlackRock Inc. (63.5K shares), MILLENNIUM MANAGEMENT LLC (19.5K shares), GEODE CAPITAL MANAGEMENT, LLC (14.5K shares), HRT FINANCIAL LP (11K shares), JACOBS LEVY EQUITY MANAGEMENT, INC (10.8K shares), SkyOak Wealth, LLC (7.41K shares), Creative Planning (7.35K shares), CITADEL ADVISORS LLC (7.11K shares), and MORGAN STANLEY (4.62K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.